Human hypoblast formation is not dependent on FGF signalling

Developmental Biology

Volumn 361, Issue 2, 2012, Pages 358-363

  Roode, Mila ^a   Blair, Kathryn ^a   Snell, Philip ^b   Elder, Kay ^b   Marchant, Sally ^c   Smith, Austin ^a   Nichols, Jennifer ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Bourn Hall Clinic ^*  (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Epiblast; Fibroblast growth factor; Human ES cell derivation; Hypoblast; Pluripotency

Indexed keywords

FIBROBLAST GROWTH FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CONTROLLED STUDY; ECTODERM; EMBRYO; EMBRYONIC STRUCTURES; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOBLAST; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

RODENTIA;

EID: 84355166507     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2011.10.030     Document Type: Article

References (44)

1. Beddington R.S., Robertson E.J. Axis development and early asymmetry in mammals. Cell 1999, 96:195-209.
2. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., de Sousa Chuva, Lopes S.M., Howlett S.K., Clarkson A., Ahrlund-Richter L., Pedersen R.A., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
3. Brook F.A., Gardner R.L. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5709-5712.
4. Buehr M., Meek S., Blair K., Yang J., Ure J., Silva J., McLay R., Hall J., Ying Q.L., Smith A. Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008, 135:1287-1298.
5. Byron S.A., Gartside M.G., Wellens C.L., Mallon M.A., Keenan J.B., Powell M.A., Goodfellow P.J., Pollock P.M. Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. Cancer Res. 2008, 68:6902-6907.
6. Cauffman G., Van de Velde H., Liebaers I., Van Steirteghem A. Oct-4 mRNA and protein expression during human preimplantation development. Mol. Hum. Reprod. 2005, 11:173-181.
7. Cauffman G., Liebaers I., Van Steirteghem A., Van de Velde H. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006, 24:2685-2691.
8. Cauffman G., De Rycke M., Sermon K., Liebaers I., Van de Velde H. Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum. Reprod. 2009, 24:63-70.
9. Champlin A.K., Dorr D.L., Gates A.H. Determining the stage of the estrous cycle in the mouse by the appearance of the vagina. Biol. Reprod. 1973, 8:491-494.
10. Chazaud C., Yamanaka Y., Pawson T., Rossant J. Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Dev. Cell 2006, 10:615-624.
11. Chen A.E., Egli D., Niakan K., Deng J., Akutsu H., Yamaki M., Cowan C., Fitz-Gerald C., Zhang K., Melton D.A., et al. Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell 2009, 4:103-106.
12. Ciuffreda P., Casati S., De Mieri M., Ferraboschi P. Corticosteroids 21-glucuronides: synthesis and complete characterization by (1)H and (13)C NMR. Steroids 2009, 74:870-875.
13. Dumoulin J.C., Meijers C.J., Bras M., Coonen E., Geraedts J.P., Evers J.L. Effect of oxygen concentration on human in-vitro fertilization and embryo culture. Hum. Reprod. 1999, 14:465-469.
14. Erlebacher A., Price K.A., Glimcher L.H. Maintenance of mouse trophoblast stem cell proliferation by TGF-beta/activin. Dev. Biol. 2004, 275:158-169.
15. Gardner R.L., Beddington R.S. Multi-lineage 'stem' cells in the mammalian embryo. J. Cell Sci. Suppl. 1988, 10:11-27.
16. Grand E.K., Chase A.J., Heath C., Rahemtulla A., Cross N.C. Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. Leukemia 2004, 18:962-966.
17. Guo G., Yang J., Nichols J., Hall J.S., Eyres I., Mansfield W., Smith A. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009, 136:1063-1069.
18. Hanna J., Cheng A.W., Saha K., Kim J., Lengner C.J., Soldner F., Cassady J.P., Muffat J., Carey B.W., Jaenisch R. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9222-9227.
19. Hyslop L., Stojkovic M., Armstrong L., Walter T., Stojkovic P., Przyborski S., Herbert M., Murdoch A., Strachan T., Lako M. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 2005, 23:1035-1043.
20. Kimber S.J., Sneddon S.F., Bloor D.J., El-Bareg A.M., Hawkhead J.A., Metcalfe A.D., Houghton F.D., Leese H.J., Rutherford A., Lieberman B.A., et al. Expression of genes involved in early cell fate decisions in human embryos and their regulation by growth factors. Reproduction 2008, 135:635-647.
21. Koto M., Miwa M., Togashi M., Tsuji K., Okamoto M., Adachi J. A method for detecting the optimum day for mating during the 4-day estrous cycle in the rat; measuring the value of electrical impedance of the vagina. Jikken Dobutsu 1987, 36:195-198.
22. Li P., Tong C., Mehrian-Shai R., Jia L., Wu N., Yan Y., Maxson R.E., Schulze E.N., Song H., Hsieh C.L., et al. Germline competent embryonic stem cells derived from rat blastocysts. Cell 2008, 135:1299-1310.
23. Liu Y., Martinez L., Ebine K., Abe M.K. Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. Dev. Biol. 2008, 314:224-235.
24. Mohammadi M., Froum S., Hamby J.M., Schroeder M.C., Panek R.L., Lu G.H., Eliseenkova A.V., Green D., Schlessinger J., Hubbard S.R. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 1998, 17:5896-5904.
25. Nichols J., Smith A. Naive and primed pluripotent states. Cell Stem Cell 2009, 4:487-492.
26. Nichols J., Ying Q.L. Derivation and propagation of embryonic stem cells in serum- and feeder-free culture. Meth. Mol. Biol. 2006, 329:91-98.
27. Nichols J., Silva J., Roode M., Smith A. Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 2009, 136:3215-3222.
28. Niwa H., Toyooka Y., Shimosato D., Strumpf D., Takahashi K., Yagi R., Rossant J. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005, 123:917-929.
29. Plusa B., Piliszek A., Frankenberg S., Artus J., Hadjantonakis A.K. Distinct sequential cell behaviours direct primitive endoderm formation in the mouse blastocyst. Development 2008, 135:3081-3091.
30. Ring D.B., Johnson K.W., Henriksen E.J., Nuss J.M., Goff D., Kinnick T.R., Ma S.T., Reeder J.W., Samuels I., Slabiak T., et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 2003, 52:588-595.
31. Silva J., Nichols J., Theunissen T.W., Guo G., van Oosten A.L., Barrandon O., Wray J., Yamanaka S., Chambers I., Smith A. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
32. Skaper S.D., Kee W.J., Facci L., Macdonald G., Doherty P., Walsh F.S. The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J. Neurochem. 2000, 75:1520-1527.
33. Smith A. Pluripotent stem cells: private obsession and public expectation. EMBO Mol. Med. 2010, 2:113-116.
34. St Bernard R., Zheng L., Liu W., Winer D., Asa S.L., Ezzat S. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. Endocrinology 2005, 146:1145-1153.
35. Stavridis M.P., Lunn J.S., Collins B.J., Storey K.G. A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 2007, 134:2889-2894.
36. Suemori H., Tada T., Torii R., Hosoi Y., Kobayashi K., Imahie H., Kondo Y., Iritani A., Nakatsuji N. Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Dev. Dyn. 2001, 222:273-279.
37. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
38. Thomson J.A., Kalishman J., Golos T.G., Durning M., Harris C.P., Becker R.A., Hearn J.P. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7844-7848.
39. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
40. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 2005, 118:4495-4509.
41. Waldenstrom U., Engstrom A.B., Hellberg D., Nilsson S. Low-oxygen compared with high-oxygen atmosphere in blastocyst culture, a prospective randomized study. Fertil. Steril. 2009, 91:2461-2465.
42. Yamanaka Y., Lanner F., Rossant J. FGF signal-dependent segregation of primitive endoderm and epiblast in the mouse blastocyst. Development 2010, 137:715-724.
43. Ying Q.L., Smith A.G. Defined conditions for neural commitment and differentiation. Meth. Enzymol. 2003, 365:327-341.
44. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.